Crossmark

Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial

Published Online: 2020-01-21

Published Print: 2020-12

Authors

Arians, Nathalie http://orcid.org/0000-0002-2389-5404
Häfner, Matthias

Krisam, Johannes

Lang, Kristin

Wark, Antje

Koerber, Stefan A.

Hommertgen, Adriane

Debus, Jürgen
License Information

Text and Data Mining valid from 2020-01-21

Version of Record valid from 2020-01-21
More Information

Article History

Received: 7 October 2019

Accepted: 16 January 2020

First Online: 21 January 2020

Ethics approval and consent to participate

: The final protocol was approved by the ethics committee of the University of Heidelberg, Heidelberg, Germany (S-296/2019). Written informed consent will be obtained from each participant before entering the trial.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current